Presentations/Presenters
Unconventional Modulation: Post-Transcriptional, Metabolite, and Co-Chaperone Influences on Steroid Receptor Function.
Presenter: Anne Elizabeth Newell-Fugate, DVM, PhD (Texas A&M University)
No relevant financial relationships
Unconventional Modulation: Post-Transcriptional, Metabolite, and Co-Chaperone Influences on Steroid Receptor Function.
Presenter: Jon Cidlowski, PhD (NIEHS/NIH)
No relevant financial relationships
Alternative Polyadenylation as a Therapeutic Vulnerability in Prostate Cancer
Presenter: Dr. Kiel Tietz, Ph.D. (University of Minnesota)
No relevant financial relationships
Alternative Polyadenylation as a Therapeutic Vulnerability in Prostate Cancer
Presenter: Jamie Van Etten, PhD (University of Minnesota)
No relevant financial relationships
Alternative Polyadenylation as a Therapeutic Vulnerability in Prostate Cancer
Presenter: Sarah Munro, PhD (University of Minnesota)
No relevant financial relationships
Alternative Polyadenylation as a Therapeutic Vulnerability in Prostate Cancer
Presenter: Jeffery Miller, PhD (University of Minnesota)
No relevant financial relationships
Alternative Polyadenylation as a Therapeutic Vulnerability in Prostate Cancer
Presenter: Scott Dehm, PhD (University of Minnesota)
No relevant financial relationships
mTOR Interacts with the Mineralocorticoid Receptor to Regulate its Activation by Ligand
Presenter: Yusuf Ali, MS, PhD (University of Mississippi Medical Center)
No relevant financial relationships
mTOR Interacts with the Mineralocorticoid Receptor to Regulate its Activation by Ligand
Presenter: Dr. Elise P. Gomez-Sanchez, DVM, PhD (University of Mississippi Medical Center)
No relevant financial relationships
mTOR Interacts with the Mineralocorticoid Receptor to Regulate its Activation by Ligand
Presenter: Celso E Gomez-Sanchez, MD (University of Mississippi Medical Center & Jackson VAMC)
No relevant financial relationships
Musashi-2 Regulatory Interactions Promote Adrenal Steroidogenesis
Presenter: Ms. Kathryn Walters, BA (University of Colorado Anschutz)
No relevant financial relationships
Musashi-2 Regulatory Interactions Promote Adrenal Steroidogenesis
Presenter: Elisabeth Murphy, BA (University of Colorado Anschutz)
No relevant financial relationships
Musashi-2 Regulatory Interactions Promote Adrenal Steroidogenesis
Presenter: Marcin Sajek, PhD (University of Colorado Anschutz)
No relevant financial relationships
Musashi-2 Regulatory Interactions Promote Adrenal Steroidogenesis
Presenter: Amber Baldwin, MS (University of Colorado Anschutz)
No relevant financial relationships
Musashi-2 Regulatory Interactions Promote Adrenal Steroidogenesis
Presenter: Neelanjan Mukherjee, PhD (University of Colorado Anschutz)
No relevant financial relationships
USP19 Deubiquitinating Enzyme Functions as a Novel Co-Chaperone of Hsp90 to Regulate Glucocorticoid Receptor Levels
Presenter: Dr. Simon Wing, BSC,MD (McGill University & McGill Univ. Health Centre)
No relevant financial relationships
USP19 Deubiquitinating Enzyme Functions as a Novel Co-Chaperone of Hsp90 to Regulate Glucocorticoid Receptor Levels
Presenter: Erin Coyne, PhD (McGill University)
No relevant financial relationships
USP19 Deubiquitinating Enzyme Functions as a Novel Co-Chaperone of Hsp90 to Regulate Glucocorticoid Receptor Levels
Presenter: Nathalie Bedard, BSc (McGill University)
No relevant financial relationships
USP19 Deubiquitinating Enzyme Functions as a Novel Co-Chaperone of Hsp90 to Regulate Glucocorticoid Receptor Levels
Presenter: Julie Huynh, BSc (McGill University)
No relevant financial relationships
USP19 Deubiquitinating Enzyme Functions as a Novel Co-Chaperone of Hsp90 to Regulate Glucocorticoid Receptor Levels
Presenter: Lenka Schorova, PhD (McGill University Health Centre)
No relevant financial relationships
USP19 Deubiquitinating Enzyme Functions as a Novel Co-Chaperone of Hsp90 to Regulate Glucocorticoid Receptor Levels
Presenter: Ewelina Rozycka, PhD (Almac Discovery)
No relevant financial relationships
USP19 Deubiquitinating Enzyme Functions as a Novel Co-Chaperone of Hsp90 to Regulate Glucocorticoid Receptor Levels
Presenter: Xavier Jacq, PhD (Almac Discovery)
No relevant financial relationships
USP19 Deubiquitinating Enzyme Functions as a Novel Co-Chaperone of Hsp90 to Regulate Glucocorticoid Receptor Levels
Presenter: Jason Young, PhD (McGill University)
No relevant financial relationships
Glucocorticoid Receptor Expression and Signaling During Critical Illness, in Relation to the Duration of Illness and the Systemic Glucocorticoid Availability: A Prospective, Observational, Cross-Sectional Human and a Translational Mouse Study
Presenter: Dr. Arno Téblick, MD (KU Leuven)
No relevant financial relationships
Glucocorticoid Receptor Expression and Signaling During Critical Illness, in Relation to the Duration of Illness and the Systemic Glucocorticoid Availability: A Prospective, Observational, Cross-Sectional Human and a Translational Mouse Study
Presenter: Lisa Van Dyck, MD, PhD (KU Leuven)
No relevant financial relationships
Glucocorticoid Receptor Expression and Signaling During Critical Illness, in Relation to the Duration of Illness and the Systemic Glucocorticoid Availability: A Prospective, Observational, Cross-Sectional Human and a Translational Mouse Study
Presenter: Nathalie Van Aerde, MD, PhD (KU Leuven)
No relevant financial relationships
Glucocorticoid Receptor Expression and Signaling During Critical Illness, in Relation to the Duration of Illness and the Systemic Glucocorticoid Availability: A Prospective, Observational, Cross-Sectional Human and a Translational Mouse Study
Presenter: Sarah Vander Perre, BSc (KU Leuven)
No relevant financial relationships
Glucocorticoid Receptor Expression and Signaling During Critical Illness, in Relation to the Duration of Illness and the Systemic Glucocorticoid Availability: A Prospective, Observational, Cross-Sectional Human and a Translational Mouse Study
Presenter: Lies Pauwels, BSc (KU Leuven)
No relevant financial relationships
Glucocorticoid Receptor Expression and Signaling During Critical Illness, in Relation to the Duration of Illness and the Systemic Glucocorticoid Availability: A Prospective, Observational, Cross-Sectional Human and a Translational Mouse Study
Presenter: Inge Derese, BSc (KU Leuven)
No relevant financial relationships
Glucocorticoid Receptor Expression and Signaling During Critical Illness, in Relation to the Duration of Illness and the Systemic Glucocorticoid Availability: A Prospective, Observational, Cross-Sectional Human and a Translational Mouse Study
Presenter: Yves Debaveye, MD, PhD (KU Leuven)
No relevant financial relationships
Glucocorticoid Receptor Expression and Signaling During Critical Illness, in Relation to the Duration of Illness and the Systemic Glucocorticoid Availability: A Prospective, Observational, Cross-Sectional Human and a Translational Mouse Study
Presenter: Pieter J Wouters, MSc (KU Leuven)
No relevant financial relationships
Glucocorticoid Receptor Expression and Signaling During Critical Illness, in Relation to the Duration of Illness and the Systemic Glucocorticoid Availability: A Prospective, Observational, Cross-Sectional Human and a Translational Mouse Study
Presenter: Ilse Vanhorebeek, PhD (KU Leuven)
No relevant financial relationships
Glucocorticoid Receptor Expression and Signaling During Critical Illness, in Relation to the Duration of Illness and the Systemic Glucocorticoid Availability: A Prospective, Observational, Cross-Sectional Human and a Translational Mouse Study
Presenter: Lies Langouche, PhD (KU Leuven)
No relevant financial relationships
Glucocorticoid Receptor Expression and Signaling During Critical Illness, in Relation to the Duration of Illness and the Systemic Glucocorticoid Availability: A Prospective, Observational, Cross-Sectional Human and a Translational Mouse Study
Presenter: Greet Van den Berghe, MD, PhD (KU Leuven)
No relevant financial relationships
The Role Of Nuclear Receptor Coregulator Grip1 In Homeostatic Programming Of Macrophages
Presenter: Marija Dacic (Physiology, Biophysics and Systems Biology, Weill Cornell Graduate School of Medical Sciences; Hospital for Special Surgery Research Institute, The David Rosenzweig Genomics Center)
No relevant financial relationships
The Role Of Nuclear Receptor Coregulator Grip1 In Homeostatic Programming Of Macrophages
Presenter: Dinesh Deochand, PhD (The David Rosenzweig Genomics Center)
No relevant financial relationships
The Role Of Nuclear Receptor Coregulator Grip1 In Homeostatic Programming Of Macrophages
Presenter: Yurii Deochand, PhD (The David Rosenzweig Genomics Center)
No relevant financial relationships
The Role Of Nuclear Receptor Coregulator Grip1 In Homeostatic Programming Of Macrophages
Presenter: Inez Rogatsky, PhD (The David Rosenzweig Genomics Center and Weill Cornell Graduate School of Medical Sciences)
No relevant financial relationships